Michelsen, BrigitteØrnbjerg, Lykke MidtbøllKvien, Tore KPavelka, KarelNissen, Michael JNordström, DanSantos, Maria JoséKoca, Suleyman SerdarAskling, JohanRotar, ZigaGudbjornsson, BjornCodreanu, CatalinLoft, Anne GitteKristianslund, Eirik KlamiMann, Herman FCiurea, AdrianEklund, Kari KVieira-Sousa, ElsaYazici, AytenJacobsson, LennartTomšič, MatijaLöve, Thorvardur JónIonescu, Ruxandravan der Horst-Bruinsma, I EIannone, FlorenzoPombo-Suarez, ManuelJones, Gareth THyldstrup, Lise HejlKrogh, Niels SteenHetland, Merete LundØstergaard, Mikkel2021-01-202021-01-202020-09-01Michelsen, B, Ørnbjerg, L M, Kvien, T K, Pavelka, K, Nissen, M J, Nordström, D, Santos, M J, Koca, S S, Askling, J, Rotar, Z, Gudbjornsson, B, Codreanu, C, Loft, A G, Kristianslund, E K, Mann, H F, Ciurea, A, Eklund, K K, Vieira-Sousa, E, Yazici, A, Jacobsson, L, Tomšič, M, Löve, T J, Ionescu, R, van der Horst-Bruinsma, I E, Iannone, F, Pombo-Suarez, M, Jones, G T, Hyldstrup, L H, Krogh, N S, Hetland, M L & Østergaard, M 2020, 'Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis', Rheumatology, vol. 59, no. 9, pp. 2455-2461. https://doi.org/10.1093/rheumatology/kez6561462-0324ORCID: /0000-0003-0016-7591/work/83703930https://hdl.handle.net/2164/15696Funding: This work was supported by Novartis. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit.7386583321410267148241603engaxial spondyloarthritispsoriatic arthritisTNF inhibitorstreatment outcomesPHYSICIANPSORIATIC-ARTHRITISR MedicinePharmacology (medical)RheumatologySupplementary DataRJournal article10.1093/rheumatology/kez656http://www.scopus.com/inward/record.url?scp=85090080184&partnerID=8YFLogxK599